Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 6/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2160987 | 0.90 | MEN1 (0.47) | MAPK1MEN1KMT2ATDP1POLB | |
| SCHEMBL12336846 | 0.90 | MEN1 (0.47) | MAPK1MEN1KMT2ATDP1POLB | |
| SCHEMBL3700015 | 0.87 | MEN1 (0.49) | MAPK1MEN1KMT2ATDP1POLB | |
| SCHEMBL1923135 | 0.87 | MEN1 (0.56) | MAPK1MEN1KMT2ATDP1POLB | |
| SCHEMBL10915818 | 0.84 | MEN1 (0.51) | MEN1KMT2ATDP1POLBHSP90AA1 | |
| SCHEMBL3230953 | 0.84 | MAPK1 (0.51) | MAPK1MEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL3233026 | 0.84 | MAPK1 (0.51) | MAPK1MEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL2159856 | 0.84 | MEN1 (0.48) | MAPK1MEN1KMT2ATDP1POLB | |
| SCHEMBL3240660 | 0.82 | MAPK1 (0.49) | MAPK1MEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL3699829 | 0.81 | MEN1 (0.47) | MEN1KMT2ATDP1POLBHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011110583-A2 | FUNGICIDAL MIXTURES COMPRISING TRIAZOLE DERIVATIVES | BASF SE (DE) | 2011-09-15 | — | — | WO | disclosed |
| US-20110183842-A1 | Triazole and Imidazole Compounds, Use Thereof and Agents Containing Them | BASF SE (DE) | 2011-07-28 | — | — | US | disclosed |
| EP-2346838-A1 | TRIAZOLE AND IMIDAZOLE COMPOUNDS, USE THEREOF AND AGENTS CONTAINING THEM | BASF SE (DE) | 2011-07-27 | — | — | EP | disclosed |
| WO-2010040718-A1 | TRIAZOLE AND IMIDAZOLE COMPOUNDS, USE THEREOF AND AGENTS CONTAINING THEM | BASF SE (DE) | 2010-04-15 | — | — | WO | disclosed |
| EP-0271790-B1 | PROCESS FOR THE PREPARATION OF PHENOXY-SUBSTITUTED ESTERS AND THEIR INTERMEDIATES | BASF Aktiengesellschaft (DE) | 1992-07-15 | — | — | EP | disclosed |
| US-5008446-A | Preparation of phenoxy-substituted esters and intermediates therefor | BASF AKTIENGESELLSCHAFT (DE) | 1991-04-16 | — | — | US | disclosed |
| EP-0236884-B1 | METHOD FOR THE PREPARATION OF PHENOXYALKANOLTRIAZOLE COMPOUNDS, AND INTERMEDIATES THEREFOR | BASF Aktiengesellschaft (DE) | 1990-12-27 | — | — | EP | disclosed |
| US-4870205-A | Preparation of phenoxy-substituted esters and intermediates therefor | BASF AKTIENGESELLSCHAFT (DE) | 1989-09-26 | — | — | US | disclosed |
| EP-0271790-A2 | Process for the preparation of phenoxy-substituted esters and their intermediates | BASF Aktiengesellschaft (DE) | 1988-06-22 | — | — | EP | disclosed |
| EP-0236884-A1 | Method for the preparation of phenoxyalkanoltriazole compounds, and intermediates therefor | BASF Aktiengesellschaft (DE) | 1987-09-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110183842-A1 | Triazole and Imidazole Compounds, Use Thereof and Agents Containing Them | OAT, ABAT, TYR | MAPK1 1464/4885MEN1 1942/4885KMT2A 2752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.